Effects of TGFβ on normal and malignant mammary epithelium

G. Zugmaier, Marc E Lippman

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The goal of our research was to determine the effects of TGFβ on differentiation and growth of normal and malignant breast epithelial cells. The influence of TGFβ on differentiation was studied in a series of normal, immortalized, and oncogene-transformed human mammary epithelial cells. The expression of human milk fat globule antigen as differentiation marker was increased ten- to fifteenfold in normal cells and two to threefold in transformed cells after treatment with 200 pM TGFβ for 30 h. All cell lines except one were growth inhibited by TGFβ. Using the estrogen receptor-positive breast cancer cell lines MCF7, ZR-75-1, T-47D, and the estrogen receptor-negative lines MDA-MB-231, SK-BR-3, Hs578T, MDA-MB-468, we found that all tested cell lines except late passage (>500) MCF7 cells were growth inhibited by TGFβ1 as well as TGFβ2. The maximal inhibition was 50% in estrogen receptor-positive and 80% in estrogen receptor-negative cell lines at concentrations of 800 and 40 pM, respectively in an anchorage-independent growth assay. All tested breast cancer cell lines secreted a TGFβ-like activity, the production of which was stimulated in MCF7 cells treated with antiestrogens and which inhibited the anchorage-independent growth of MDA-MB-231 cells. These observations suggest that the malignant phenotype in breast cancer need not be coupled with resistance to effects of TGFβ on growth and differentiation. Breast cancer cells being resistant to treatment with antiestrogens are still growth inhibited by TGFβ in vitro. This may partially explain the growth inhibitory effects of antiestrogens in mixtures of estrogen receptor-positive and -negative tumour cell populations in vivo.

Original languageEnglish
Pages (from-to)272-275
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume593
DOIs
StatePublished - Sep 25 1990
Externally publishedYes

Fingerprint

Breast
Epithelium
Cells
Estrogen Receptors
Growth
Estrogen Receptor Modulators
Cell Line
Breast Neoplasms
MCF-7 Cells
Epithelial Cells
Differentiation Antigens
Cell growth
Human Milk
Oncogenes
Tumors
Assays
Antigens
Phenotype
Research
Population

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effects of TGFβ on normal and malignant mammary epithelium. / Zugmaier, G.; Lippman, Marc E.

In: Annals of the New York Academy of Sciences, Vol. 593, 25.09.1990, p. 272-275.

Research output: Contribution to journalArticle

Zugmaier, G. ; Lippman, Marc E. / Effects of TGFβ on normal and malignant mammary epithelium. In: Annals of the New York Academy of Sciences. 1990 ; Vol. 593. pp. 272-275.
@article{603ecc49160747d782249f64a72d2fa5,
title = "Effects of TGFβ on normal and malignant mammary epithelium",
abstract = "The goal of our research was to determine the effects of TGFβ on differentiation and growth of normal and malignant breast epithelial cells. The influence of TGFβ on differentiation was studied in a series of normal, immortalized, and oncogene-transformed human mammary epithelial cells. The expression of human milk fat globule antigen as differentiation marker was increased ten- to fifteenfold in normal cells and two to threefold in transformed cells after treatment with 200 pM TGFβ for 30 h. All cell lines except one were growth inhibited by TGFβ. Using the estrogen receptor-positive breast cancer cell lines MCF7, ZR-75-1, T-47D, and the estrogen receptor-negative lines MDA-MB-231, SK-BR-3, Hs578T, MDA-MB-468, we found that all tested cell lines except late passage (>500) MCF7 cells were growth inhibited by TGFβ1 as well as TGFβ2. The maximal inhibition was 50{\%} in estrogen receptor-positive and 80{\%} in estrogen receptor-negative cell lines at concentrations of 800 and 40 pM, respectively in an anchorage-independent growth assay. All tested breast cancer cell lines secreted a TGFβ-like activity, the production of which was stimulated in MCF7 cells treated with antiestrogens and which inhibited the anchorage-independent growth of MDA-MB-231 cells. These observations suggest that the malignant phenotype in breast cancer need not be coupled with resistance to effects of TGFβ on growth and differentiation. Breast cancer cells being resistant to treatment with antiestrogens are still growth inhibited by TGFβ in vitro. This may partially explain the growth inhibitory effects of antiestrogens in mixtures of estrogen receptor-positive and -negative tumour cell populations in vivo.",
author = "G. Zugmaier and Lippman, {Marc E}",
year = "1990",
month = "9",
day = "25",
doi = "10.1111/j.1749-6632.1990.tb16118.x",
language = "English",
volume = "593",
pages = "272--275",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effects of TGFβ on normal and malignant mammary epithelium

AU - Zugmaier, G.

AU - Lippman, Marc E

PY - 1990/9/25

Y1 - 1990/9/25

N2 - The goal of our research was to determine the effects of TGFβ on differentiation and growth of normal and malignant breast epithelial cells. The influence of TGFβ on differentiation was studied in a series of normal, immortalized, and oncogene-transformed human mammary epithelial cells. The expression of human milk fat globule antigen as differentiation marker was increased ten- to fifteenfold in normal cells and two to threefold in transformed cells after treatment with 200 pM TGFβ for 30 h. All cell lines except one were growth inhibited by TGFβ. Using the estrogen receptor-positive breast cancer cell lines MCF7, ZR-75-1, T-47D, and the estrogen receptor-negative lines MDA-MB-231, SK-BR-3, Hs578T, MDA-MB-468, we found that all tested cell lines except late passage (>500) MCF7 cells were growth inhibited by TGFβ1 as well as TGFβ2. The maximal inhibition was 50% in estrogen receptor-positive and 80% in estrogen receptor-negative cell lines at concentrations of 800 and 40 pM, respectively in an anchorage-independent growth assay. All tested breast cancer cell lines secreted a TGFβ-like activity, the production of which was stimulated in MCF7 cells treated with antiestrogens and which inhibited the anchorage-independent growth of MDA-MB-231 cells. These observations suggest that the malignant phenotype in breast cancer need not be coupled with resistance to effects of TGFβ on growth and differentiation. Breast cancer cells being resistant to treatment with antiestrogens are still growth inhibited by TGFβ in vitro. This may partially explain the growth inhibitory effects of antiestrogens in mixtures of estrogen receptor-positive and -negative tumour cell populations in vivo.

AB - The goal of our research was to determine the effects of TGFβ on differentiation and growth of normal and malignant breast epithelial cells. The influence of TGFβ on differentiation was studied in a series of normal, immortalized, and oncogene-transformed human mammary epithelial cells. The expression of human milk fat globule antigen as differentiation marker was increased ten- to fifteenfold in normal cells and two to threefold in transformed cells after treatment with 200 pM TGFβ for 30 h. All cell lines except one were growth inhibited by TGFβ. Using the estrogen receptor-positive breast cancer cell lines MCF7, ZR-75-1, T-47D, and the estrogen receptor-negative lines MDA-MB-231, SK-BR-3, Hs578T, MDA-MB-468, we found that all tested cell lines except late passage (>500) MCF7 cells were growth inhibited by TGFβ1 as well as TGFβ2. The maximal inhibition was 50% in estrogen receptor-positive and 80% in estrogen receptor-negative cell lines at concentrations of 800 and 40 pM, respectively in an anchorage-independent growth assay. All tested breast cancer cell lines secreted a TGFβ-like activity, the production of which was stimulated in MCF7 cells treated with antiestrogens and which inhibited the anchorage-independent growth of MDA-MB-231 cells. These observations suggest that the malignant phenotype in breast cancer need not be coupled with resistance to effects of TGFβ on growth and differentiation. Breast cancer cells being resistant to treatment with antiestrogens are still growth inhibited by TGFβ in vitro. This may partially explain the growth inhibitory effects of antiestrogens in mixtures of estrogen receptor-positive and -negative tumour cell populations in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0025046018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025046018&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1990.tb16118.x

DO - 10.1111/j.1749-6632.1990.tb16118.x

M3 - Article

C2 - 2375597

AN - SCOPUS:0025046018

VL - 593

SP - 272

EP - 275

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -